MeiraGTx Holdings (MGTX) Times Interest Earned (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Times Interest Earned of $8.67 for Q4 2025, up 193.86% on a YoY basis from $2.95 in Q4 2024, and up 157.67% quarter-over-quarter from -$15.02 in Q3 2025.
MeiraGTx Holdings (MGTX) Times Interest Earned (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Times Interest Earned for 9 years, with the latest figure at $8.67 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 193.86% year-over-year to $8.67; the trailing twelve-month figure through Dec 2025 stood at -$8.69 (up 29.78% YoY), and the FY2025 full-year result was -$8.69, up 29.78% from the prior year.
- Times Interest Earned for Q4 2025 stood at $8.67, up from -$15.02 in the prior quarter.
- The five-year high for Times Interest Earned was $8.67 in Q4 2025, with the low at -$401.63 in Q2 2021.
- Historically, Times Interest Earned has averaged -$101.84 across 5 years, with a median of -$14.14 in 2022.
- Annual changes were most pronounced in 2024 — Times Interest Earned tumbled 64.44% — and 2025, when it jumped 193.86%.
- MeiraGTx Holdings' Times Interest Earned stood at -$64.62 in 2021, then soared by 78.05% to -$14.18 in 2022, then increased by 10.54% to -$12.69 in 2023, then climbed by 27.23% to -$9.23 in 2024, then soared by 193.86% to $8.67 in 2025.
- The last three Times Interest Earned figures came in at $8.67 (Q4 2025), -$15.02 (Q3 2025), and -$14.76 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 8.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.67 |
| Sep 30, 2025 | -15.02 |
| Jun 30, 2025 | -14.76 |
| Mar 31, 2025 | -13.67 |
| Dec 31, 2024 | -9.23 |
| Sep 30, 2024 | -11.93 |
| Jun 30, 2024 | -14.11 |
| Mar 31, 2024 | -14.39 |
| Dec 31, 2023 | -12.69 |
| Sep 30, 2023 | -9.69 |
| Jun 30, 2023 | -8.58 |
| Mar 31, 2023 | -10.38 |
| Dec 31, 2022 | -14.18 |
| Sep 30, 2022 | -12.05 |
| Jun 30, 2022 | -289.73 |
| Mar 31, 2022 | -373.17 |
| Dec 31, 2021 | -64.62 |
| Sep 30, 2021 | -382.24 |
| Jun 30, 2021 | -401.63 |
| Mar 31, 2021 | -373.42 |